Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call

Ref: Syn/CS/SE/BM/2022-23/July/16

July 26, 2022

To, The Manager, BSE Limited Corporate Relationship Department Dalal Street, Mumbai – 400 001 Scrip Code: 539268

Dear Sir/Madam,

Syngene International Limited Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560099, Karnataka, India. T +91 80 6891 8000 F +91 80 6891 8808 CIN: L85110KA1993PLC01493 www.syngeneintl.com

To, The Manager, National Stock Exchange of India Limited Corporate Communication Department Bandra (EAST), Mumbai – 400 051 Scrip Symbol: SYNGENE

Subject: Intimation of transcript for Q1 FY23 post earnings call

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), please find the link for the transcript of the Q1 FY23 Earnings Call conducted on July 21, 2022 and uploaded on website of the Company on July 26, 2022.

Particulars Earnings Call Transcript

Website link https://cdn.syngeneintl.com/2022/07/26214819/Syngene- Q1FY23-Earnings-Call-Transcript.pdf

The Investors Presentation was submitted to the Stock exchanges on July 20, 2022 and uploaded on the website on the same day.

Request to kindly take this intimation on record.

Thanking You,

Yours faithfully, For SYNGENE INTERNATIONAL LIMITED

____________________ Priyadarshini Mahapatra Company Secretary and Compliance Officer